BioClinica, Inc. Launches WebSend and Creates Efficiencies for Clinical Trial Imaging Delivery

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, today announced the release of BioClinica WebSend, a system that simplifies and accelerates image collection for clinical studies. WebSend transfers and tracks medical images in real-time, offering key benefits over the standard manual transport methods commonly used in imaging trials, including faster delivery of image data, enhanced data quality with fewer site queries, and reduced cost.

MORE ON THIS TOPIC